Every cigarette warning label in America talks about the lungs, the heart, and pregnancy. None of them mentions the eyes. Yet the disease that takes the central vision of more older Americans than any other — age-related macular degeneration — sits on the short list of conditions the United States government has formally concluded cigarettes cause. In its landmark 2014 report, The Health Consequences of Smoking—50 Years of Progress, the U.S. Surgeon General concluded that the evidence is sufficient to infer a causal relationship between cigarette smoking and age-related macular degeneration. A person can spend a lifetime reading warnings about emphysema and heart attacks and never once be told that the same product could cost them their sight.
This piece continues the firm's series on the harms cigarettes cause that the public rarely connects to smoking — the cancers few smokers are warned about, and the cardiovascular diseases that strike far from the lungs. Macular degeneration belongs in that company. It is not a cancer, and it is rarely fatal, which is precisely why it almost never enters the conversation about tobacco liability — and why it deserves one. Below: what macular degeneration is and why it matters, why it sits on the Surgeon General's list of conditions smoking causes, the biology that explains an eye disease driven by a lung habit, how large the smoking risk really is, why quitting matters more here than almost anywhere else, the “it was just your age and your genes” defense, and how a smoking-related vision-loss claim fits the same liability framework the firm uses in its lung cancer, COPD, and other smoking-disease matters.
What Macular Degeneration Is
The macula is the small, central part of the retina responsible for the sharp, straight-ahead vision used to read, drive, recognize a face, and thread a needle. Age-related macular degeneration is the progressive breakdown of that tissue. It comes in two forms. Dry (atrophic) AMD is the far more common type, in which yellowish deposits called drusen accumulate beneath the retina and the light-sensing cells slowly thin and die. Wet (neovascular) AMD is less common but more aggressive: fragile new blood vessels grow under the retina and leak fluid and blood, causing rapid, severe loss of central vision if untreated.
AMD does not usually cause total blindness — peripheral vision typically survives — but the loss of the central field is disabling in its own right. It ends the ability to read ordinary print, to drive safely, and to see the details of the world at arm's length. According to the National Eye Institute, part of the National Institutes of Health, AMD is the leading cause of vision loss among Americans aged 50 and older. Its early stages often produce no symptoms at all, which is why a dilated eye exam — and an honest accounting of a patient's smoking history — matters long before the vision is gone.
Why Macular Degeneration Is on the Surgeon General's Smoking List
The link here is not a plaintiff's theory. It is the conclusion of the government's highest scientific authority on tobacco. The 2014 Surgeon General's report was the first to add age-related macular degeneration to the list of diseases for which the evidence is sufficient to infer a causal relationship with cigarette smoking — the same standard of proof the report applies to lung cancer, stroke, and the other classic smoking diseases. The finding did not stand alone. The U.S. Food and Drug Administration tells the public that smoking increases the risk of both cataracts and age-related macular degeneration, the Centers for Disease Control and Prevention lists vision loss and blindness among the harms of smoking, and the American Academy of Ophthalmology identifies smoking as one of the few modifiable risk factors consistently tied to the disease.
What makes the AMD finding striking is how far it sits from the lungs. An organ that never touches smoke, sealed behind the blood supply, is nonetheless damaged by a lifetime of inhaling it — the same lesson the firm's guides to kidney cancer and bladder cancer describe for organs downstream of the bloodstream. The eye is not on the pack. It should be.
The Biology: How a Lung Habit Reaches the Retina
The macula is one of the most metabolically active tissues in the body, and it depends on a rich, delicate blood supply and a constant defense against oxidative stress. Cigarette smoking attacks it on several fronts at once. The mechanisms described by ophthalmology and vision-science sources include:
- Oxidative damage. Tobacco smoke is a concentrated source of oxidant chemicals. Absorbed through the lungs into the bloodstream, they generate oxidative stress in the retina — the very kind of cellular damage the macula's antioxidant defenses exist to prevent.
- Reduced blood and oxygen flow. Smoking narrows and damages small blood vessels throughout the body. In the eye, it reduces blood and oxygen flow to the choroid, the vascular layer that nourishes the retina — starving the exact tissue AMD destroys.
- Depleted protective pigment. Research indicates smoking lowers the density of macular pigment — the lutein and zeaxanthin that shield the macula from light-driven damage — and impedes the body's antioxidant defenses, leaving the retina more vulnerable.
- Harmful inflammation. Laboratory studies show cigarette-smoke extract can injure retinal cells and activate the complement cascade, an arm of the immune system that vision scientists have specifically implicated in the development of macular degeneration.
It is the same theme that runs through this entire series: the carcinogens and toxins in cigarette smoke do not stay where the smoke goes. They enter the blood and reach organs the smoker never imagined were at risk — here, the few square millimeters of tissue that carry a person's sharpest sight.
How Big Is the Smoking Risk?
Large, dose-dependent, and — unusually — reversible with cessation. Public-health and ophthalmology sources place the risk of age-related macular degeneration in smokers at roughly two to four times that of people who never smoked, with the risk climbing as the number of cigarettes and years of smoking rise. The following points come from the Surgeon General's evaluation, the American Academy of Ophthalmology, the National Eye Institute, and the vision-research literature:
- Roughly two to four times the risk of AMD among smokers compared with never-smokers, with heavy, long-term smoking carrying the highest risk — the dose-response gradient epidemiologists treat as a signature of genuine causation.
- Pack-a-day smokers are commonly described as roughly doubling their likelihood of the advanced, sight-threatening disease compared with non-smokers.
- Smoking is associated not only with getting AMD but with getting it earlier and progressing faster — long-term studies of the natural history of the disease link cigarette smoking to a greater risk of advancing to the late, vision-destroying stage.
- The excess risk declines after a person quits; former smokers carry a lower risk than current smokers, and long-term quitters approach — though the literature suggests they may not fully reach — the risk of those who never smoked.
A two-to-fourfold increase in the leading cause of vision loss among older Americans is not a statistical footnote. Where a longtime smoker loses central vision to macular degeneration, cigarettes belong on the short list of causes that actually explain it — a conclusion the Surgeon General reached only after the evidence demanded it.
A Distinctive Fact: Quitting Is the One Thing That Works
Age-related macular degeneration has no cure. Wet AMD can be managed with injections that slow its progression, and certain nutritional supplements can slow the advance of intermediate dry AMD, but the underlying disease cannot be reversed. Against that backdrop, one fact stands out: stopping smoking is the single modifiable step consistently shown to lower the risk of AMD. Age cannot be changed. Family history cannot be changed. Smoking can — and it is the one lever the science says actually moves the odds.
That fact cuts two ways in these cases. It underscores how preventable much of this vision loss was, had the danger been understood and acted on in time — a danger the warning labels never named. And it sharpens the causal picture: when the one clearly modifiable cause of a smoker's AMD was the cigarettes they were never warned about, the product's role is difficult to wave away.
The Defense: “It Was Just Your Age and Your Genes”
Because AMD is, by definition, age-related, and because genetics play a real part in it, expect the tobacco defendants to lean on both: everyone's eyes fail with age — this was time and DNA, not our product. The argument trades on real risk factors. It still falls short of ending a case.
Age and genes are risk factors that a person cannot change; that does not make smoking any less of a cause where it was present. Smoking is an independent, Surgeon-General-recognized cause of AMD, and in product-liability law a manufacturer whose product was a substantial contributing factor to an injury does not escape responsibility by naming other factors that also contributed. Where a smoker's advancing years, their family history, and decades of cigarettes all acted on the same retina, the sound question is not which one caused the vision loss but whether the cigarettes were a substantial factor in causing it — and the government's causal conclusion is the starting point for showing they were. This mirrors the “it was the drinking,” “it was the HPV,” and “it was his job” deflections the firm answers throughout this series in its oral and throat cancer and nasal and sinus cancer guides: a second cause is a fact to be accounted for, not a defense that clears the product.
The Legal Framework
Smoking-related macular degeneration cases proceed on the same liability theories as other smoking-disease cases against the tobacco industry:
- Negligent design, manufacture, and marketing of cigarettes.
- Strict product liability for an unreasonably dangerous product.
- Failure to warn about the full range of harms smoking causes — including a leading cause of blindness that appears on no cigarette warning label and in almost no public-health campaign.
- Fraud and misrepresentation about the safety and addictiveness of the products.
- Civil conspiracy among manufacturers to suppress and distort health research.
The internal industry records unearthed in prior tobacco litigation — the documents showing what the companies knew about the harms of their product and when — remain central evidence. Our companion piece on how tobacco companies hid the truth walks through that record. Alex Alvarez, the firm's Managing Partner and a Board Certified Civil Trial Lawyer, brings that documentary history together with each client's own smoking and medical records to build the causation case a vision-loss claim requires, and to answer the “it was just your age” defense described above.
Sorting a genuine smoking-driven case from ordinary age-related change is medical work as much as legal work, and it is where the firm's Medical-Legal Expert earns his place. Herb Borroto, M.D., J.D., who holds both a medical degree and a law degree, reads the ophthalmology records, the imaging that documents the drusen and the wet-versus-dry distinction, the age of onset, and the smoking history measured in pack-years together — recognizing when an early or fast-progressing AMD in a longtime smoker points to tobacco as a substantial contributing cause, in a way a purely legal review has no reason to look for and a purely clinical review has no reason to connect to liability.
What a Macular Degeneration Case Needs
- Documentation of the diagnosis — the ophthalmology and optometry records, the retinal imaging (OCT and fundus photography), the dry-versus-wet classification, and the stage of the disease.
- A substantial smoking history, measured in pack-years, spanning the years the science associates with the disease.
- The age of onset and the pattern of progression — particularly early or unusually rapid disease, which can help distinguish a smoking-driven case from ordinary age-related change.
- Brand identification — which cigarettes or tobacco products were used, and for how long.
- Causation testimony from an appropriate expert familiar with the smoking–AMD literature.
- Documentation of the impact on daily life — the loss of the ability to drive, read, work, or live independently that central vision loss brings.
Unlike many of the cancers in this series, a macular degeneration matter is usually brought by the living, injured smoker rather than as a wrongful death claim, because AMD is disabling rather than fatal. The unglamorous paperwork behind these elements is what carries the case. Our guide to smoking history documentation covers the records that build or break a tobacco claim.
The Jurisdictions We Serve
The Alvarez Law Firm represents smokers and families in Hawaii, Illinois, Nevada, Oregon, Pennsylvania, and the U.S. Virgin Islands. Each of those jurisdictions has its own filing deadlines, its own substantive law on tobacco product liability, and its own version of the discovery rule — how long after a diagnosis a claim must be filed. Because those deadlines are unforgiving and easy to overlook while a person is absorbed in adjusting to failing vision, talk to counsel licensed in the relevant state about how they apply to your situation. Waiting can foreclose options that were available earlier.
Frequently Asked Questions
Does smoking cause macular degeneration?
Yes. In its 2014 report, The Health Consequences of Smoking—50 Years of Progress, the U.S. Surgeon General concluded that the evidence is sufficient to infer a causal relationship between cigarette smoking and age-related macular degeneration (AMD), the leading cause of vision loss among older Americans. The FDA, the Centers for Disease Control and Prevention, and the American Academy of Ophthalmology all identify smoking as a major, well-established risk factor for the disease. Because AMD also runs with age and genetics, a longtime smoker who is losing central vision should have the record reviewed by counsel.
How much does smoking raise the risk of macular degeneration?
Public-health and ophthalmology sources put the risk at roughly two to four times that of people who never smoked, and the risk rises with the amount and duration of smoking. Pack-a-day smokers are commonly described as roughly doubling their risk of the advanced disease. The excess risk declines after a person quits but can remain elevated for years, and quitting is the single modifiable step consistently shown to lower AMD risk. Because AMD is common in older people generally, the smoking history measured in pack-years, the age of onset, and the pattern of progression all matter to how a case is evaluated.
Can you bring a claim for vision loss rather than a cancer?
Potentially. Tobacco liability is not limited to cancer. Age-related macular degeneration is a serious, often permanent injury — the loss of the central vision used to read, drive, and recognize faces — and smoking is a Surgeon-General-recognized cause of it. Unlike many smoking cancers, an AMD case is usually brought by the living, injured smoker rather than as a wrongful death claim. Because AMD also has strong age and genetic components, these cases turn on a careful reading of the smoking history against the medical record, and every jurisdiction has its own filing deadline, so a smoker losing central vision should speak with counsel licensed in the relevant state.
If You or a Family Member Has Been Diagnosed
If you have a substantial smoking history and have been diagnosed with age-related macular degeneration — or you are watching a loved one lose their sight to it — a free, confidential case review is the right next step. The same conversation that produces a viable lung cancer case can produce a viable vision-loss case, even though the eye appears on no warning label.
- Start at the lungs, where most smoking cases begin: Lung Cancer and Your Legal Rights and COPD After Years of Smoking.
- Read about other organs cigarettes reach through the bloodstream: Kidney Cancer and Bladder Cancer.
- Learn how the industry concealed the harms: How Tobacco Companies Hid the Truth.
Free case review. No fees unless we recover compensation for you.
Sources
- U.S. Department of Health and Human Services, Office of the Surgeon General — The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General (2014), which concluded that the evidence is sufficient to infer a causal relationship between cigarette smoking and age-related macular degeneration. hhs.gov/surgeongeneral
- U.S. Food and Drug Administration — "How Smoking Can Contribute to Vision Loss and Blindness," stating that smoking increases the risk of cataracts and age-related macular degeneration. fda.gov
- Centers for Disease Control and Prevention — "Vision Loss, Blindness, and Smoking," identifying age-related macular degeneration among the vision harms caused by smoking. cdc.gov
- National Eye Institute, National Institutes of Health — "Age-Related Macular Degeneration (AMD)," describing AMD as a leading cause of vision loss in older adults, the dry and wet forms, and smoking as a risk factor. nei.nih.gov
- American Academy of Ophthalmology — patient education identifying smoking as one of the few modifiable risk factors consistently associated with age-related macular degeneration. aao.org